S.Biomedics Co., Ltd. (KOSDAQ:304360)
South Korea flag South Korea · Delayed Price · Currency is KRW
24,000
-1,500 (-5.88%)
Last updated: Mar 28, 2025

S.Biomedics Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Operating Revenue
13,73413,10812,1138,8685,319
Upgrade
Other Revenue
---0--0
Upgrade
Revenue
13,73413,10812,1138,8685,319
Upgrade
Revenue Growth (YoY)
4.77%8.22%36.59%66.72%6.09%
Upgrade
Cost of Revenue
7,0276,5556,0024,5494,022
Upgrade
Gross Profit
6,7076,5546,1114,3191,298
Upgrade
Selling, General & Admin
5,6655,4144,2243,3573,365
Upgrade
Research & Development
5,8506,5085,4895,5255,559
Upgrade
Operating Expenses
12,14912,5439,8638,9479,731
Upgrade
Operating Income
-5,442-5,989-3,752-4,628-8,433
Upgrade
Interest Expense
-795.15-883.54-727.42-674.93-514.96
Upgrade
Interest & Investment Income
310.05266.24146.72101.0597.05
Upgrade
Currency Exchange Gain (Loss)
83.9539.5317.2191.56-16.89
Upgrade
Other Non Operating Income (Expenses)
-159.85-2,665-918.38-151.52184.2
Upgrade
EBT Excluding Unusual Items
-6,003-9,232-5,234-5,262-8,684
Upgrade
Gain (Loss) on Sale of Investments
76.1292.6123.870.2489.31
Upgrade
Gain (Loss) on Sale of Assets
-5.49---
Upgrade
Other Unusual Items
169.48-0.48-12.82-
Upgrade
Pretax Income
-5,757-9,134-5,210-5,249-8,594
Upgrade
Income Tax Expense
63.79123.24-455.23-6.59-4.55
Upgrade
Earnings From Continuing Operations
-5,821-9,258-4,755-5,242-8,590
Upgrade
Minority Interest in Earnings
-869.84-1,063-1,572-424.81842.53
Upgrade
Net Income
-6,691-10,321-6,327-5,667-7,747
Upgrade
Net Income to Common
-6,691-10,321-6,327-5,667-7,747
Upgrade
Shares Outstanding (Basic)
1111101010
Upgrade
Shares Outstanding (Diluted)
1111101010
Upgrade
Shares Change (YoY)
5.15%6.98%0.67%0.42%3.93%
Upgrade
EPS (Basic)
-582.00-944.00-619.09-558.24-766.36
Upgrade
EPS (Diluted)
-582.00-944.00-619.09-558.24-766.36
Upgrade
Free Cash Flow
-4,890-7,996-12,501-3,762-5,620
Upgrade
Free Cash Flow Per Share
-425.40-731.37-1223.19-370.56-555.91
Upgrade
Gross Margin
48.84%50.00%50.45%48.70%24.40%
Upgrade
Operating Margin
-39.62%-45.69%-30.98%-52.19%-158.54%
Upgrade
Profit Margin
-48.72%-78.73%-52.23%-63.90%-145.65%
Upgrade
Free Cash Flow Margin
-35.61%-61.00%-103.20%-42.42%-105.65%
Upgrade
EBITDA
-3,717-4,436-2,235-3,180-7,084
Upgrade
EBITDA Margin
-27.06%-33.84%-18.45%-35.86%-133.17%
Upgrade
D&A For EBITDA
1,7251,5531,5171,4481,349
Upgrade
EBIT
-5,442-5,989-3,752-4,628-8,433
Upgrade
EBIT Margin
-39.62%-45.69%-30.98%-52.19%-158.54%
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.